New arthritis pill shows promise in Mid-Stage trial

NCT ID NCT07335952

Summary

This study tested a new daily pill called Proximod for people with active rheumatoid arthritis who weren't getting enough relief from standard medications. About 179 participants took either Proximod or a placebo pill for three months to see if it reduced joint swelling and pain. The goal was to find the right dose and see if this new approach could help control the disease.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RHEUMATOID ARTHRITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Chun Li

    Beijing, Beijing Municipality, 100044, China

  • Guixiu Shi

    Xiamen, Fujian, 361003, China

  • Hua Zhang

    Zaozhuang, Shandong, 277100, China

  • Huaxiang Wu

    Hangzhou, Zhejiang, 310009, China

  • Jian Wu

    Suzhou, Jiangsu, 215006, China

  • Jiashun Zeng

    Guiyang, Guizhou, 550004, China

  • Ling Lei

    Nanning, Guangxi, 530021, China

  • Lingli Dong

    Wuhan, Hubei, 430030, China

  • Mei Tian

    Zunyi, Guizhou, 563099, China

  • Mingwei Deng

    Guangzhou, Guangdong, China

  • Qingwen Wang

    Shenzhen, Guangdong, 518036, China

  • Senhua Dai

    Pingxiang, Jiangxi, 337055, China

  • Shulin Song

    Yichang, Hubei, 43003, China

  • Weiqi Min

    Heze, Shandong, 274006, China

  • Wubin Long

    Chengdu, Sichuan, 610072, China

  • Xiaofei Shi

    Luoyang, Henan, 471000, China

  • Xuebinwang

    Binzhou, Shandong, 256603, China

  • Yanmei Wu

    Panjin, Liaoning, 124000, China

  • Yi He

    Guangzhou, Guangdong, 510630, China

  • Zili Fu

    Taiyuan, Shanxi, 030001, China

Conditions

Explore the condition pages connected to this study.